By: Amelia Gibson, PhD, MBA, Senior Director of Product Licensing at Kerafast and Absolute Antibody It’s rare that one gets to participate in something as historic and globally impactful as the development of a COVID-19 vaccine. While I know little about vaccine development and no longer do any benchwork, I knew that I could contribute
Here at Kerafast, our company mission is to facilitate access to unique reagents developed by academic laboratories worldwide on behalf of the scientific community. Together with our providing investigators, we work to distribute reagents that might otherwise have been sitting unused in laboratory freezers to researchers committed to furthering scientific progress. The COVID-19 outbreak made
At Kerafast, we understand that lab managers play a vital role in the research community through their indispensable contributions to the lab. This past holiday season, we invited our community of scientists to nominate their lab manager to enter a random drawing for the chance to win a $1000 gift card plus $250 for their
At Kerafast, we understand that lab managers play a vital role in the research community through their indispensable contributions to the lab. This past holiday season, we invited our community of scientists to nominate their lab manager to enter a random drawing for the chance to win a $1000 gift card plus $250 for their
BioNTech recently published an announcement expressing gratitude to its employees and various partners who have assisted the company in developing a successful COVID-19 vaccine. The BioNTech-Pfizer vaccine has been shown to be 95% effective in preventing COVID-19 and it has received emergency use authorizations from more than 45 countries around the world. Kerafast is very